Focus on Oral, Head, Neck & Thyroid Cancers

 

Photo by Cancer Type

Managing Speech and Swallowing Complications Resulting from Head and Neck Cancer

by Jan S. Lewin, PhD

Head and neck cancer often results in significant functional changes in speech, voice, and swallowing. These problems can occur as a result of the disease or of the treatment. It is important to have a thorough and real­istic understanding of the functional effects of treatment because the restora­tion of communication and the ability to swallow may be critical to your treatment decision.

Read More

 

Photo by Cancer Type

Swallowing Exercises Shown to Preserve Function in People with Head and Neck Cancer Receiving Radiation

A study from UCLA’s Jonsson Com­prehensive Cancer Center has found that people with head and neck cancer receiv­ing radiation as part of their treatment were less likely to experience unwanted side effects such as worsening of diet, need for a feeding tube, or narrowing of the throat passage if they complied with a set of prescribed swallowing exercises during therapy.

Read More

 

Photo by Cancer Type

FDA Approves Nexavar to Treat Type of Thyroid Cancer

The U.S. Food and Drug Administration has expanded the approved uses of Nexavar (sorafenib) to treat late-stage (metastatic) differentiated thyroid cancer. The drug’s new use is intended for patients with locally recurrent or metastatic, progressive differentiated thyroid cancer that no longer responds to radioactive iodine treatment.

Read More